AGDUFA Meetings
Animal Generic Drug User Fee Act
Industry Discussions on AGDUFA V Reauthorization
- September 9, 2026 Meeting Minutes
- August 26, 2026 Meeting Minutes
- August 5, 2026 Meeting Minutes
- July 23, 2026 Meeting Minutes
2026 Public Meeting - May 27, 2026
- FDA Announces 2026 Virtual Public Meetings and Comment Periods on Reauthorization of User Fee Programs for Animal Drugs and Generic Animal Drugs
- 2026 Meeting Information
- 2026 Meeting Presentations
- 2026 Meeting Transcript
2022 Public Meeting - October 26, 2022
- FDA Announces 2022 Public Meeting and Comment Period on Reauthorization of Animal Generic Drug User Fee Program
- 2022 Meeting Information
- 2022 Notice of Public Meeting and Request for Comments
- Animal Generic Drug User Fee Act Reauthorization Performance Goals and Procedures – Fiscal Years 2024 Through 2028
- 2022 Public Meeting Recording
- 2022 Public Meeting Presentation
- 2022 Public Meeting Transcript
- AGDUFA IV Summary of Public Comments
2021 Public Meeting
- 2021 FDA Public and Stakeholder Meetings on Reauthorization of Two Animal Drug User Fee Programs
- 2021 Notice of Public Meeting and Request for Comments
- 2021 Meeting Recording
- 2021 Meeting Transcript
- 2021 Meeting Presentation from FDA
- 2021 GADA Presentation
Industry Discussions on AGDUFA IV Reauthorization
- October 21, 2021 Meeting Minutes
- September 28, 2021 Meeting Minutes
- September 21, 2021 Meeting Minutes
- September 16, 2021 Meeting Minutes
- August 24, 2021 Meeting Minutes
- August 3, 2021 Meeting Minutes
- July 22, 2021 Meeting Minutes
- July 14, 2021 Meeting Minutes
Please see the FDA Archive for older meeting information.